AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price was up 2.2% during mid-day trading on Monday . The company traded as high as $37.30 and last traded at $36.33. Approximately 21,584 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 313,014 shares. The stock had previously closed […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,240,000 shares, a decrease of 7.5% from the September 15th total of 1,340,000 shares. Based on an average trading volume of 323,000 shares, the short-interest ratio is […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given an average recommendation of “Buy” by the four analysts that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued ratings on the stock in the last […]
Commerce Bank grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 5.6% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 11,357 shares of the medical device company’s stock after acquiring an additional 602 shares during the period. Commerce Bank’s holdings in AtriCure were worth […]
Advisors Capital Management LLC lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 25.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,208 shares of the medical device company’s stock after acquiring an additional 11,529 shares during the […]